文献速递甲状腺疾病肥胖与代谢综合征

甲状腺功能与甲状腺功能正常成人不同肥胖表型发生的关系:九年随访

Association Between Thyroid Function and Development of Different Obesity Phenotypes in Euthyroid Adults: A Nine-Year Follow-Up.
PubMed 文献 · Thyroid · 2018-04-05

基于德黑兰甲状腺研究1938名甲状腺功能正常成人,随访9.2年,采用广义估计方程分析。血清游离甲状腺素每升高1 ng/dL,代谢健康正常体重表型风险增加1.65倍(CI 1.09-2.5),代谢健康肥胖表型风险降低50%(OR=0.50,CI 0.32-0.76);促甲状腺激素与代谢不健康正常体重表型正相关(OR=1.22,CI 1.01-1.48)。

要点

  • 游离甲状腺素每升高1 ng/dL,代谢健康正常体重风险增加1.65倍(CI 1.09-2.5)。
  • 游离甲状腺素每升高1 ng/dL,代谢健康肥胖风险降低50%(OR=0.50,CI 0.32-0.76)。
  • 促甲状腺激素与代谢不健康正常体重表型正相关(OR=1.22,CI 1.01-1.48)。

核心结论

  • 血清游离甲状腺素在参考范围内与部分肥胖表型(代谢健康正常体重和代谢健康肥胖)的发生相关,已考虑潜在混杂因素。

研究设计与样本

  • 基于德黑兰甲状腺研究这一正在进行的人群队列,纳入1938名个体,随访9.2年。
  • 根据体重指数和代谢状态将参与者分为四种肥胖表型。
  • 采用基于广义估计方程的多变量方法分析促甲状腺激素和游离甲状腺素与不同肥胖表型发生的关系。

主要发现

  • 基线时代谢健康正常体重表型者血清游离甲状腺素水平较高(1.2 ± 0.16 ng/dL vs. 代谢健康肥胖1.14 ± 0.14 ng/dL、代谢不健康正常体重1.16 ± 0.14 ng/dL、代谢不健康肥胖1.17 ± 0.15 ng/dL)。
  • 多变量调整年龄、性别、吸烟、体力活动、教育水平、甲状腺过氧化物酶抗体状态和稳态模型评估-胰岛素抵抗后,参考范围内游离甲状腺素每升高1 ng/dL,随访9.2年间发生代谢健康正常体重表型的风险增加1.65倍(CI 1.09-2.5)。
  • 参考范围内游离甲状腺素每升高1.0 ng/dL,发生代谢健康肥胖表型的风险降低50%(OR=0.50,CI 0.32-0.76)。
  • 血清促甲状腺激素水平与代谢不健康正常体重表型发生呈显著正相关(OR=1.22,CI 1.01-1.48)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Considering inconsistent and conflicting data on associations of thyroid function, within the reference range, with anthropometric measures and metabolic syndrome, this study aimed to investigate the relationship between thyroid function and different obesity phenotypes over nine years of follow-up. METHODS: This study was conducted on 1938 individuals from an ongoing population-based cohort study, the Tehran Thyroid Study. Participants were categorized into four obesity phenotypes based on body mass index and metabolic status. To investigate the associations of thyrotropin and free thyroxine (fT4) with incidence of different obesity phenotypes across the study period, a multivariate approach based on a generalized estimating equation method was used. RESULTS: At baseline, individuals with the metabolically healthy normal weight (MHNW) phenotype had higher serum fT4 levels (1.2 ± 0.16 ng/dL vs. 1.14 ± 0.14 ng/dL, 1.16 ± 0.14 ng/dL, and 1.17 ± 0.15 ng/dL in metabolically healthy obese [MHO], metabolically unhealthy normal weight, and metabolically unhealthy obese individuals, respectively). The results of the generalized estimating equation analysis after multivariate adjustment for age, sex, smoking, physical activity, education level, thyroid peroxidase antibody status, and homeostasis model assessment-insulin resistance showed that each 1 ng/dL increment in fT4 levels within the reference range was accompanied with a 1.65-fold [confidence interval (CI) 1.09-2.5] increase of developing the MHNW phenotype during 9.2 years of follow-up. Moreover, each 1.0 ng/dL increment in fT4 within the reference range was associated with a 50% decreased risk of developing the MHO phenotype (odds ratio = 0.50 [CI 0.32-0.76]). Meanwhile, a significant positive association was found between serum thyrotropin levels and development of the metabolically unhealthy normal weight phenotype (odds ratio = 1.22 [CI 1.01-1.48]). CONCLUSIONS: Serum fT4 concentrations within the reference range are associated with the development of some obesity phenotypes, including the MHNW and MHO phenotypes, after consideration of potential confounders.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Amouzegar A, Kazemian E, Abdi H, et al. Association Between Thyroid Function and Development of Different Obesity Phenotypes in Euthyroid Adults: A Nine-Year Follow-Up. Thyroid. 2018. PMID: 29620968. doi:10.1089/thy.2017.0454

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。